gut-restricted pan-JAK inhibitors (Topivert Pharma)

N/A

Report date: 2025/03/20 16:08:05
NME

Base Information

Drug Namegut-restricted pan-JAK inhibitors (Topivert Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitors
TargetsJanus kinase
Therapy Area/IndicationsAsthmaInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTopivert Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTopivert Pharma Ltd
Inactive CompaniesN/A
Active IndicationsAsthmaInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A